International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 2 , Pages 567-574, 1 June 2009

Frameless Stereotactic Body Radiotherapy for Lung Cancer Using Four-Dimensional Cone Beam CT Guidance

  • Jan-Jakob Sonke, Ph.D.

      Affiliations

    • Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    • Corresponding Author InformationReprint requests to: J.-J. Sonke, Department of Radiation Oncology, Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. Tel: (+31) 20-5121723; Fax: (+31) 20-6691101
  • ,
  • Maddalena Rossi, R.T.T.

      Affiliations

    • Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • ,
  • Jochem Wolthaus, M.Sc.

      Affiliations

    • Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • ,
  • Marcel van Herk, Ph.D.

      Affiliations

    • Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • ,
  • Eugene Damen, Ph.D.

      Affiliations

    • Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • ,
  • Jose Belderbos, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Received 14 May 2008; received in revised form 8 August 2008; accepted 10 August 2008. published online 28 November 2008.

Purpose

To quantify the localization accuracy and intrafraction stability of lung cancer patients treated with frameless, four-dimensional (4D) cone beam computed tomography (CBCT)-guided stereotactic body radiotherapy (SBRT) and to calculate and validate planning target volume (PTV) margins to account for the residual geometric uncertainties.

Materials and Methods

Sixty-five patients with small peripheral lung tumors were treated with SBRT without a body frame to 54 Gy in three fractions. For each fraction, three 4D-CBCT scans were acquired: before treatment to measure and correct the time-weighted mean tumor position, after correction to validate the correction applied, and after treatment to estimate the intrafraction stability. Patient-specific PTV margins were computed and subsequently validated using Monte Carlo error simulations.

Results

Systematic tumor localization inaccuracies (1 SD) were 0.8, 0.8, and 0.9 mm for the left-right, craniocaudal, and anteroposterior direction, respectively. Random localization inaccuracies were 1.1, 1.1, and 1.4 mm. Baseline variations were 1.8, 2.9, and 3.0 mm (systematic) and 1.1, 1.5, and 2.0 mm (random), indicating the importance of image guidance. Intrafraction stability of the target was 1.2, 1.2, and 1.8 mm (systematic) and 1.3, 1.5, and 1.8 mm (random). Monte Carlo error simulations showed that patient-specific PTV margins (5.8–10.5 mm) were adequate for 94% of the evaluated cases (2–28 mm peak-to-peak breathing amplitude).

Conclusions

Frameless SBRT can be safely administered using 4D-CBCT guidance. Even with considerable breathing motion, the PTV margins can safely be kept small, allowing patients with larger tumors to benefit from the advantages of SBRT. In case bony anatomy would be used as a surrogate for tumor position, considerably larger PTV margins would be required.

Stereotactic body radiotherapy (SBRT), Image-guided radiotherapy (IGRT), Geometrical uncertainties, Margins, Four-dimensional cone beam CT (4D-CBCT)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Research partly sponsored by grants of Elekta Oncology Systems.

PII: S0360-3016(08)03268-9

doi:10.1016/j.ijrobp.2008.08.004

International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 2 , Pages 567-574, 1 June 2009